Neurology · Bayonne, NJ
NPI
1356457246
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
956 Kennedy Blvd
Bayonne, NJ, 07002
Phone (201) 858-2457
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
3,674 services
Medicare patients, 2024
152
Average age 75
Drug cost, 2024
$1.7M
1,858 prescriptions
Company payments, 2025
$2,618
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Charles was code 99214 (office e&m - established), 136 times for 85 patients. In total James A Charles billed 3,674 services in 21 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 136 | 85 | $107.40 | $15K |
| 99213 Office E&M - Established | Office | 62 | 49 | $73.84 | $4,578 |
| 99215 Office E&M - Established | Office | 52 | 36 | $150.79 | $7,841 |
| 99497 Care Management/Coordination | Office | 36 | 33 | $65.08 | $2,343 |
| 95886 Electrical Nerve Conductivity | Office | 33 | 20 | $85.39 | $2,818 |
| 99205 Office E&M - New | Office | 27 | 27 | $190.49 | $5,143 |
| 99204 Office E&M - New | Office | 26 | 26 | $144.97 | $3,769 |
| 95908 Electrical Nerve Conductivity | Office | 13 | 13 | $97.69 | $1,270 |
| 96116 Behavioral Health Services | Office | 12 | 12 | $78.46 | $942 |
By year: 2022 $72K for 6,400 services; 2023 $88K for 6,047 services; 2024 $67K for 3,674 services.
Medicare prescription drug claims, 2024
In 2024, the drug James A Charles prescribed most often to Medicare patients was Donepezil Hcl, with 113 prescriptions and refills. In total James A Charles wrote 1,858 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 113 | 155 | 28 | $839 |
| Rytary Carbidopa/Levodopa | 87 | 124 | 15 | $44K |
| Topiramate Generic | 81 | 137 | 15 | $813 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 72 | 135 | 19 | $1,875 |
| Olanzapine Generic | 67 | 75 | 14 | $523 |
| Ajovy Autoinjector Fremanezumab-Vfrm | 65 | 86 | 14 | $60K |
| Rasagiline Mesylate Generic | 58 | 84 | Under 11 | $6,431 |
| Nurtec Odt Rimegepant Sulfate | 57 | 60 | 20 | $87K |
| Qulipta Atogepant | 56 | 56 | 11 | $60K |
| Memantine Hcl Generic | 52 | 76 | Under 11 | $1,175 |
| Gabapentin Generic | 49 | 80 | 13 | $674 |
| Aimovig Autoinjector Erenumab-Aooe | 46 | 54 | 11 | $38K |
| Levetiracetam Generic | 38 | 61 | Under 11 | $1,588 |
| Clonazepam Generic | 36 | 36 | Under 11 | $218 |
| Dexamethasone Generic | 35 | 35 | 17 | $214 |
Brand drugs: - claims; generic drugs: 1,143 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Charles $2,618 ($2,618 in general payments such as food, travel and fees) from 20 companies. The largest payer was Abbvie Inc. with $566.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 36 | $566 |
| Axsome Therapeutics, Inc. AXSM | 25 | $390 |
| Pfizer Inc. PFE | 33 | $334 |
| Amneal Pharmaceuticals LLC AMRX | 18 | $285 |
| Lundbeck LLC | 19 | $252 |
| Teva Pharmaceuticals USA, Inc. TEVA | 15 | $180 |
| Celgene Corporation BMY | 5 | $83.06 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $82.22 |
| Scilex Pharmaceuticals Inc. | 4 | $62.7 |
| Impel Pharmaceuticals LLC | 3 | $58.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.